Alkylating medications (6/13 = 46
Alkylating medications (6/13 = 46.2%), tyrosine kinase inhibitors (6/14 = 42.9%), and antimetabolites (6/15 = 40%) exerted comparable outcomes. to take care of multiple myeloma. [18,19,20,21,22,23]. Structurally, they comprise the dimers of six different monoxanthones generally, which are connected at the two 2,2 positions with similar molecular weights (638.1635) and also have the molecular formulae […]